Skip to Content

UBS Should Benefit From Credit Suisse Takeover Despite Challenges

UBS must minimize revenue attrition and execute a radical restructuring of CS’ business.

A photo of the facade of the Credit Suisse building.

UBS Stock at a Glance

Current Morningstar Fair Value Estimate: $22.80

Stock Star Rating: 4 Stars

Economic Moat Rating: Narrow

Moat Trend Rating: Stable

UBS Stock Update

A week can be a very long time in financial markets. UBS UBS acquiring Credit Suisse CS for CHF 3 billion a week ago would have seemed like a terrific deal. Now the position is less clear. Credit Suisse likely experienced significant net outflows of client assets last week, eroding its revenue base.

We, however, believe that UBS can extract value from the acquisition. It is in a much better position to execute a radical restructuring of Credit Suisse’s business than Credit Suisse was. We calculate that the UBS 2027 cost savings target would reduce Credit Suisse’s 2022 adjusted operating expenses by around 60%. The restructuring will come with material costs, but UBS is better placed than Credit Suisse to absorb this.

The challenge for UBS will be to keep revenue attrition to a minimum during the restructuring period. In a surprise move, the Swiss regulators wrote down the value of Credit Suisse CHF 16 billion additional Tier 1 capital to zero, providing UBS with additional capital to absorb markdowns and restructuring charges. In addition, the Swiss authorities will provide a further CHF 9 billion of downside protection.

The combined CHF 25 billion of downside protection plus, if needed, liquidity support from the Swiss central bank should hopefully ensure that UBS wholesale funding costs remain in check. The suspension of UBS’ share buyback program is negative, but it could have happened regardless, given current market conditions. We will update our fair value estimate for UBS shortly.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.

More in Stocks

About the Author

Johann Scholtz

Equity Analyst
More from Author

Johann Scholtz, CFA, is an equity analyst for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. He covers European banks.

Before joining Morningstar in 2017, Scholtz covered South African banks, asset managers, and consumer goods firms for more than a decade at various South African buy- and sell-side firms.

Scholtz holds a bachelor's degree in accounting from Stellenbosch University. He also holds the Chartered Financial Analyst® designation and is a qualified chartered accountant.

Sponsor Center